Related references
Note: Only part of the references are listed.Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and Challenges
Martina Perse et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Development and validation of a LC-MS/MS assay for quantification of cisplatin in rat plasma and urine
Abdul Naveed Shaik et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)
Effect of Liver Disease on Hepatic Transporter Expression and Function
Nilay Thakkar et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Effect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir
Tomas Laho et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Addressing phenoconversion: the Achilles' heel of personalized medicine
Rashmi R. Shah et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Mechanism of Altered Metformin Distribution in Nonalcoholic Steatohepatitis
John D. Clarke et al.
DIABETES (2015)
Renal Xenobiotic Transporter Expression is Altered in Multiple Experimental Models of Nonalcoholic Steatohepatitis
Mark J. Canet et al.
DRUG METABOLISM AND DISPOSITION (2015)
Renal Circadian Clock Regulates the Dosing-Time Dependency of Cisplatin-Induced Nephrotoxicity in Mice
Masayuki Oda et al.
MOLECULAR PHARMACOLOGY (2014)
Modeling Human Nonalcoholic Steatohepatitis-Associated Changes in Drug Transporter Expression Using Experimental Rodent Models
Mark J. Canet et al.
DRUG METABOLISM AND DISPOSITION (2014)
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2
Jason A. Sprowl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Organic cation transporter OCT/SLC22A and H+/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents
Atsushi Yonezawa et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics
Atsushi Yonezawa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Relationship between Kidney Function and Liver Histology in Subjects with Nonalcoholic Steatohepatitis
Giovanni Targher et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Role of glutathione S-transferase Pi in cisplatin-induced nephrotoxicity
Danyelle M. Townsend et al.
BIOMEDICINE & PHARMACOTHERAPY (2009)
Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity
K. K. Filipski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Mechanistic Comparison of Human High-Affinity Copper Transporter 1-Mediated Transport between Copper Ion and Cisplatin
Zheng D. Liang et al.
MOLECULAR PHARMACOLOGY (2009)
Interaction of cisplatin with the human organic cation transporter 2
Kelly K. Filipski et al.
CLINICAL CANCER RESEARCH (2008)
Cisplatin: a review of toxicities and therapeutic applications
K. Barabas et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2008)
Transport of cisplatin by the copper efflux transporter ATP7B
Roohangiz Safaei et al.
MOLECULAR PHARMACOLOGY (2008)
The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells
K Katano et al.
MOLECULAR PHARMACOLOGY (2003)
Metabolism of cisplatin to a nephrotoxin in proximal tubule cells
DM Townsend et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae
XJ Lin et al.
MOLECULAR PHARMACOLOGY (2002)
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
S Ishida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Pharmacokinetics and toxicodynamics of cisplatin and its metabolites in rats: Relationship between renal handling and nephrotoxicity of cisplatin
K Hanada et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2000)
Share Paper
